Navigation Links
Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007

Radi Medical Systems Sponsors Case Review with Drs. Morton Kern, Nico

Pijls, Augusto Pichard

UPPSALA, Sweden and WILMINGTON, Mass., Oct. 19 /PRNewswire/ -- The use of fractional flow reserve (FFR) for optimizing patient outcomes is the topic of several sessions at this year's Transcatheter Cardiovascular Therapeutics symposium, TCT 2007, which will take place Oct. 20-25 in Washington.

Radi Medical Systems AB, the first company to develop systems that calculate FFR with the physiologic assessment of targeted lesions, is sponsoring a breakfast session, Nine Cases That Will Change Your Practice: FFR Case Review, at 7 a.m. EDT on Oct. 23 in room No. 152 B in the Washington Convention Center. Morton J. Kern, M.D., of the University of California- Irvine, is the session's moderator, while Nico Pijls, M.D., Ph.D. of Catharina Hospital, Eindhoven, the Netherlands, and Augusto Pichard, M.D., of the Washington Hospital Center, are the participating faculty.

In addition to coverage in the case review, FFR and physiologic lesion assessment are the subject of:

-- An extensive workshop at 2 p.m. on Oct. 21 that will focus on the

basics of FFR measurement, the use of FFR in specific settings, and the

practicalities and impact of FFR in the era of drug-eluting stents

(Room 147AB)

-- A session on Oct. 22 during the "Board Review Course with Self

Assessment for Interventional Cardiology and Endovascular Medicine,

PART 3: Coronary Essentials" that will cover IVUS and physiologic

lesion assessment in clinical practice and physiologic lesion

assessment case presentations with an integrated Q&A (Room 146AB)

About FFR

FFR expresses maximum achievable blood flow in a coronary artery with abnormal stenosis as a fraction of normal maximum blood flow in the absence of a stenosis. It is calculated using an interventional guidewire with a specially designed sensor built into it. Using the well established value of 0.75, FFR is 100% specific in identifying which lesions are actually causing flow restriction and can be treated. FFR also documents the exact percentage of the reduction in flow associated with each lesion.

About Radi Medical Systems AB

Radi Medical Systems AB (Radi) develops, manufactures and sells medical devices designed to improve patient care. The company's pioneering work in the field of interventional cardiology has resulted in market-leading intravascular sensors and hemostasis management and radiology devices. Radi works closely with medical practitioners to develop solutions that address clinical needs, as well as provide clinical education support. Founded in 1988, Radi employs more than 350 people globally and has representation in more than 40 countries. The company is based in Uppsala, Sweden, and maintains a U.S. headquarters in Wilmington, Mass. For more information, visit

Editor's Note: Radi Medical Systems will display its latest products at booth No. 2085 at TCT 2007.

Media Contacts:

David Schull or Benjamin Carmichael

Russo Partners

+1 212-845-4271

+1 858-717-2310 (during TCT 2007)

Jim Archetto

Radi Medical Systems

+1 877-337-7234 ext. 812

SOURCE Radi Medical Systems AB
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
2. Optimizing pfuturbo DNA Polymerase Amplification Reactions with Perfect Match PCR Enhancer
3. Optimizing electroporation parameters
4. Optimizing Büchi® Rotary Evaporator Applications
5. Optimizing electroporation parameters
6. Optimizing Büchi® Rotary Evaporator Applications
7. Optimizing Bchi Rotary Evaporator Applications
8. Optimizing electroporation parameters
9. Optimizing electroporation parameters
10. Optimizing electroporation parameters
11. Optimizing electroporation parameters
Post Your Comments:
(Date:11/27/2015)... , November 27, 2015 ... Growing popularity of companion diagnostics is ... cancer biomarkers market with pharmaceutical companies and ... companion diagnostic tests. . ... Complete report on global cancer biomarkers ...
(Date:11/25/2015)... , November 26, 2015 ... Biobanking Market 2016 - 2020 report analyzes that ... integrity and quality in long-term samples, minimizing manual ... cost-effectiveness. Automation minimizes manual errors such as mislabeling ... efficiency. Further, it plays a vital role in ...
(Date:11/25/2015)... -- Studies reveal the differences in species ... the way for more effective treatment for one of the ... --> --> Gum disease ... cats, yet relatively little was understood about the bacteria associated ... conducted by researchers from the WALTHAM Centre for Pet Nutrition ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
Breaking Biology Technology:
(Date:10/29/2015)... MINNETONKA, Minn. , Oct. 29, 2015   ... that supports the entire spectrum of clinical research, is ... the Minnesota High Tech Association (MHTA) as one of ... in the "Software – Small and Growing" category. The ... and individuals who have shown superior technology innovation and ...
(Date:10/29/2015)... Connecticut , October 29, 2015 ... a biometric authentication company focused on the growing ... smart wallet announces that StackCommerce, a leading marketplace ... be featuring the Wocket® smart wallet on StackSocial ... NXTD ) ("NXT-ID" or the "Company"), a biometric ...
(Date:10/26/2015)... October 26, 2015 ... adds Biometrics Market Shares, ... as well as Emerging Biometrics Technologies: ... to its collection of IT and ... . --> ...
Breaking Biology News(10 mins):